{"id":"https://openalex.org/W2184879005","doi":"https://doi.org/10.1158/1535-7163.mct-04-0261","title":"A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3","display_name":"A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3","publication_year":2005,"publication_date":"2005-03-01","ids":{"openalex":"https://openalex.org/W2184879005","doi":"https://doi.org/10.1158/1535-7163.mct-04-0261","mag":"2184879005","pmid":"https://pubmed.ncbi.nlm.nih.gov/15767551"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-04-0261","doi":"https://doi.org/10.1158/1535-7163.mct-04-0261","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-04-0261","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011301983","display_name":"Xenia Jimenez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105962","display_name":"Recombinant Antibody Technology (United Kingdom)","ror":"https://ror.org/01tmhf693","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210105962"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Xenia Jimenez","raw_affiliation_strings":["1Antibody Technology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antibody Technology, Departments of","institution_ids":["https://openalex.org/I4210105962"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108767488","display_name":"Dan Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105962","display_name":"Recombinant Antibody Technology (United Kingdom)","ror":"https://ror.org/01tmhf693","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210105962"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dan Lu","raw_affiliation_strings":["1Antibody Technology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antibody Technology, Departments of","institution_ids":["https://openalex.org/I4210105962"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Laura Brennan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105962","display_name":"Recombinant Antibody Technology (United Kingdom)","ror":"https://ror.org/01tmhf693","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210105962"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura Brennan","raw_affiliation_strings":["1Antibody Technology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antibody Technology, Departments of","institution_ids":["https://openalex.org/I4210105962"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026263385","display_name":"Kris Persaud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kris Persaud","raw_affiliation_strings":["2Molecular and Cell Biology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Molecular and Cell Biology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Meilin Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105962","display_name":"Recombinant Antibody Technology (United Kingdom)","ror":"https://ror.org/01tmhf693","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210105962"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Meilin Liu","raw_affiliation_strings":["1Antibody Technology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antibody Technology, Departments of","institution_ids":["https://openalex.org/I4210105962"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109143404","display_name":"Hua\u2010Quan Miao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huaquan Miao","raw_affiliation_strings":["3Protein Science, ImClone Systems Incorporated, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Protein Science, ImClone Systems Incorporated, New York, New York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109922991","display_name":"Larry Witte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larry Witte","raw_affiliation_strings":["2Molecular and Cell Biology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Molecular and Cell Biology, and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102120005","display_name":"Zhenping Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105962","display_name":"Recombinant Antibody Technology (United Kingdom)","ror":"https://ror.org/01tmhf693","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210105962"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zhenping Zhu","raw_affiliation_strings":["1Antibody Technology, Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Antibody Technology, Departments of","institution_ids":["https://openalex.org/I4210105962"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0649,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.86775589,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"4","issue":"3","first_page":"427","last_page":"434"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9419999718666077},{"id":"https://openalex.org/keywords/diabodies","display_name":"diabodies","score":0.9750000238418579},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.9150000214576721},{"id":"https://openalex.org/keywords/vegfr-3","display_name":"VEGFR-3","score":1.0},{"id":"https://openalex.org/keywords/vegf-c","display_name":"VEGF-C","score":0.7680000066757202},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.7279999852180481},{"id":"https://openalex.org/keywords/lymphangiogenesis","display_name":"lymphangiogenesis","score":0.9850000143051147},{"id":"https://openalex.org/keywords/endothelial-cell-migration","display_name":"endothelial cell migration","score":0.8730000257492065},{"id":"https://openalex.org/keywords/mitogen-activated-protein-kinase","display_name":"mitogen-activated protein kinase","score":0.8119999766349792},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.6620000004768372},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.5460000038146973}],"concepts":[{"id":"https://openalex.org/C2776636583","wikidata":"https://www.wikidata.org/wiki/Q6708231","display_name":"Lymphangiogenesis","level":4,"score":0.7288956642150879},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6897604465484619},{"id":"https://openalex.org/C14858245","wikidata":"https://www.wikidata.org/wiki/Q18028241","display_name":"Kinase insert domain receptor","level":5,"score":0.6754464507102966},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.6319670081138611},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5861247777938843},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5790057182312012},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5219642519950867},{"id":"https://openalex.org/C103041312","wikidata":"https://www.wikidata.org/wiki/Q7916457","display_name":"Vascular endothelial growth factor C","level":5,"score":0.5151904821395874},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5122303366661072},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.431873619556427},{"id":"https://openalex.org/C146285616","wikidata":"https://www.wikidata.org/wiki/Q7916455","display_name":"Vascular endothelial growth factor A","level":4,"score":0.3840245008468628},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.37073564529418945},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35175198316574097},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.24557480216026306},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22331368923187256},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.206755131483078},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18950408697128296},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1391465663909912},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001011","descriptor_name":"Aorta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002417","descriptor_name":"Cattle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004306","descriptor_name":"Dose-Response Relationship, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014471","descriptor_name":"Umbilical Veins","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D017434","descriptor_name":"Protein Structure, Tertiary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040301","descriptor_name":"Vascular Endothelial Growth Factor Receptor-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D040301","descriptor_name":"Vascular Endothelial Growth Factor Receptor-2","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D040321","descriptor_name":"Vascular Endothelial Growth Factor Receptor-3","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D040321","descriptor_name":"Vascular Endothelial Growth Factor Receptor-3","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-04-0261","doi":"https://doi.org/10.1158/1535-7163.mct-04-0261","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-04-0261","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:15767551","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15767551","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W161146849","https://openalex.org/W1592045168","https://openalex.org/W1600324901","https://openalex.org/W1664817186","https://openalex.org/W1756949381","https://openalex.org/W1892920531","https://openalex.org/W1963876488","https://openalex.org/W1967174628","https://openalex.org/W1967841898","https://openalex.org/W1970053353","https://openalex.org/W1982246723","https://openalex.org/W1985666931","https://openalex.org/W2008691375","https://openalex.org/W2023052504","https://openalex.org/W2026642794","https://openalex.org/W2035181064","https://openalex.org/W2036260794","https://openalex.org/W2050358495","https://openalex.org/W2051421411","https://openalex.org/W2051601925","https://openalex.org/W2062138347","https://openalex.org/W2066639629","https://openalex.org/W2073262381","https://openalex.org/W2073704598","https://openalex.org/W2076424556","https://openalex.org/W2078653335","https://openalex.org/W2080098573","https://openalex.org/W2080267208","https://openalex.org/W2083867249","https://openalex.org/W2094618776","https://openalex.org/W2098671787","https://openalex.org/W2099368276","https://openalex.org/W2100525694","https://openalex.org/W2105681978","https://openalex.org/W2117452881","https://openalex.org/W2120614448","https://openalex.org/W2123386346","https://openalex.org/W2124389647","https://openalex.org/W2141046053","https://openalex.org/W2149278865","https://openalex.org/W2159599793"],"related_works":["https://openalex.org/W2339782521","https://openalex.org/W2123386346","https://openalex.org/W2212264615","https://openalex.org/W2169006682","https://openalex.org/W2053428753","https://openalex.org/W2140512094","https://openalex.org/W2111628999","https://openalex.org/W2562015523","https://openalex.org/W2006142583","https://openalex.org/W1987088569"],"abstract_inverted_index":{"Vascular":[0],"endothelial":[1,69,139,154],"growth":[2,25,57],"factors":[3],"(VEGF)":[4],"and":[5,19,21,26,43,48,60,65,76,95,105,111,117,127,133,150,168],"their":[6],"receptors":[7],"(VEGFR)":[8],"have":[9],"been":[10],"implicated":[11],"to":[12,93,97,102,146,177],"play":[13],"important":[14],"roles":[15],"in":[16,23,107,138],"tumor-associated":[17],"angiogenesis":[18],"lymphangiogenesis,":[20],"hence":[22],"tumor":[24],"metastasis.":[27],"We":[28],"previously":[29],"produced":[30,77],"a":[31,78,81,108,162,173],"number":[32],"of":[33,55,67,88,130,153,165],"fully":[34],"human":[35,68],"antibodies":[36,52],"directed":[37],"against":[38],"VEGF":[39,44,126,149],"receptor":[40,45,62],"2":[41],"(VEGFR2)":[42],"3":[46],"(VEGFR3)":[47],"showed":[49],"that":[50,161],"these":[51],"are":[53],"capable":[54],"inhibiting":[56],"factor":[58],"(VEGF":[59],"VEGF-C)-induced":[61],"activation,":[63],"migration,":[64],"proliferation":[66],"cells.":[70,140,155],"In":[71,119],"this":[72],"report,":[73],"we":[74],"constructed":[75],"bispecific":[79],"antibody,":[80],"diabody,":[82],"using":[83],"the":[84,122,142],"variable":[85],"domain":[86],"genes":[87],"two":[89],"neutralizing":[90],"antibodies,":[91],"IMC-1121":[92],"VEGFR2":[94,104,167],"hF4-3C5":[96],"VEGFR3.":[98],"The":[99],"diabody":[100,123,143],"binds":[101],"both":[103,125,148,166],"VEGFR3":[106,169],"dose-dependent":[109],"manner,":[110],"blocks":[112],"interaction":[113],"between":[114],"VEGF/VEGFR2,":[115],"VEGF-C/VEGFR2,":[116],"VEGF-C/VEGFR3.":[118],"cell-based":[120],"assays,":[121],"neutralized":[124],"VEGF-C-stimulated":[128],"activation":[129],"VEGFR2,":[131],"VEGFR3,":[132],"p44/p42":[134],"mitogen-activated":[135],"protein":[136],"kinase":[137],"Furthermore,":[141],"was":[144],"able":[145],"inhibit":[147],"VEGF-C-induced":[151],"migration":[152],"Taken":[156],"together,":[157],"our":[158],"results":[159],"suggest":[160],"dual":[163],"blockade":[164],"simultaneously":[170],"may":[171],"represent":[172],"more":[174],"potent":[175],"approach":[176],"effective":[178],"cancer":[179],"therapy.":[180]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}